University of Groningen
Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A Therapeutic Option in Systemic
Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121
Abdulle, Amaal Eman; van Goor, Harry; Mulder, Douwe J
Published in:
International Journal of Molecular Sciences
DOI:
10.3390/ijms20225663
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2019
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Abdulle, A. E., van Goor, H., & Mulder, D. J. (2019). Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A
Therapeutic Option in Systemic Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121: A Therapeutic Option in
Systemic Sclerosis (vol 19, 4121, 2018). International Journal of Molecular Sciences, 20(22), [5663].
https://doi.org/10.3390/ijms20225663
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.
International Journal of
Molecular Sciences
Correction
Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A
Therapeutic Option in Systemic Sclerosis. Int. J. Mol.
Sci. 2018, 19, 4121
Amaal Eman Abdulle1,* , Harry van Goor2,† and Douwe J. Mulder1,†
1 Department of Internal Medicine, Division Vascular Medicine, University of Groningen, University Medical
Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands; d.j.mulder@umcg.nl
2 Department of Pathology and Medical Biology, Section Pathology, University of Groningen, University
Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands; h.van.goor@umcg.nl
* Correspondence: a.eman.abdulle@umcg.nl; Tel.:+31-50-361-3400; Fax: +31-50-361-3312
† These authors contributed equally to this work.
Received: 25 October 2019; Accepted: 4 November 2019; Published: 12 November 2019
The authors wish to make the following correction to this paper [1].
Reference [8] refers to the wrong article. The correct reference [2] should be:
Abdulle, A.E.; Diercks, G.F.H.; Feelisch, M.; Mulder, D.J.; van Goor, H. The Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy. Front. Physiol. 2018, 9, 1–15, doi:10.3389/fphys.2018.01177.
The authors would like to apologize for any inconvenience caused to the readers by these changes.
References
1. Abdulle, A.E.; van Goor, H.; Mulder, D.J. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis.
Int. J. Mol. Sci. 2018, 19, 4121. [CrossRef] [PubMed]
2. Abdulle, A.E.; Diercks, G.F.H.; Feelisch, M.; Mulder, D.J.; van Goor, H. The Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy. Front. Physiol. 2018, 9, 1–15. [CrossRef] [PubMed] © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
